16065-Lymphomas-Non-Hodgkins-519

Lymphomas

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-Hodgkin�s Lymphoma (UTX-TGR-205)

  • Details

ClinicalTrials.gov ID: NCT02793583
Diagnosis Type: Non-Hodgkins
USOR Number:

  • Address


,
P:

Search by practice name, trial titles, indicators and specific disease types.

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.